Clinical Drug Experience Knowledgebase

COVID-19 Vaccines

Anaphylaxis (Phase 3)

Arthritis (Early Phase 1)

Arthritis, Juvenile (Phase 2)

Arthritis, Psoriatic (Early Phase 1)

Arthritis, Rheumatoid (Phase 3)

Chronic Disease (Phase 2)

Coronavirus Infections (Phase 4)

COVID-19 (Phase 4)

COVID-19 Vaccines (Phase 4)

Dermatomyositis (Phase 2)

Drug-Related Side Effects and Adverse Reactions (Phase 4)

Gout (Early Phase 1)

Healthy Volunteers (Phase 2)

Hematologic Neoplasms (Phase 2)

Herpes Zoster (Phase 3)

Hypersensitivity (Phase 2)

Immune System Diseases (Phase 4)

Immunocompromised Host (Phase 3)

Immunoglobulin Light-chain Amyloidosis (Phase 2)

Infections (Phase 1)

Inflammation (Early Phase 1)

Injection Site Reaction (Phase 4)

Kidney Diseases (Phase 4)

Kidney Transplantation (Phase 2)

Leukemia (Phase 2)

Leukemia, Lymphocytic, Chronic, B-Cell (Phase 2)

Liver Transplantation (Phase 2)

Lupus Erythematosus, Systemic (Phase 3)

Lymphoma (Phase 2)

Mast Cell Activation Disorders (Phase 2)

Multiple Myeloma (Phase 2)

Multiple Sclerosis (Phase 4)

Neoplasms (Phase 4)

Osteoarthritis (Early Phase 1)

Pain (Phase 4)

Papillomavirus Infections (Phase 3)

Pemphigus (Phase 2)

Pneumococcal Infections (Phase 3)

Quality of Life (Phase 4)

Renal Insufficiency, Chronic (Phase 2/Phase 3)

Rheumatic Diseases (Phase 3)

SARS-CoV-2 (Phase 3)

Sclerosis (Phase 2)

Severe Acute Respiratory Syndrome (Phase 4)

Sjogren's Syndrome (Early Phase 1)

Spondylitis, Ankylosing (Early Phase 1)

Vaccination (Phase 2)

Vaccine-Preventable Diseases (Phase 4)

Vaccines (Phase 4)